2018 ESSO/ESCP/SIOG/ACS专家建议:老年直肠癌患者的个体化管理

2018-08-15 欧洲肿瘤外科学会 Eur J Surg Oncol. 2018 Aug 15.

2018年8月,欧洲肿瘤外科学会(ESSO)、欧洲肛肠病学学会(ESCP)、国际老年肿瘤学会(SIOG)以及美国外科医师协会(ACS)癌症委员会共同发布了老年直肠癌患者的个体化管理建议,主要建议内容涉及多学科团队管理,患者优化,手术治疗,局部晚期疾病的治疗,肝转移同步治疗以及促进恢复路径等。

中文标题:

2018 ESSO/ESCP/SIOG/ACS专家建议:老年直肠癌患者的个体化管理

英文标题:

Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Su

发布机构:

欧洲肿瘤外科学会

发布日期:

2018-08-15

简要介绍:

2018年8月,欧洲肿瘤外科学会(ESSO)、欧洲肛肠病学学会(ESCP)、国际老年肿瘤学会(SIOG)以及美国外科医师协会(ACS)癌症委员会共同发布了老年直肠癌患者的个体化管理建议,主要建议内容涉及多学科团队管理,患者优化,手术治疗,局部晚期疾病的治疗,肝转移同步治疗以及促进恢复路径等。 

拓展指南:直肠癌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 ESSO/ESCP/SIOG/ACS专家建议:老年直肠癌患者的个体化管理)] GetToolGuiderByIdResponse(projectId=1, id=407e71c00163a3b7, title=2018 ESSO/ESCP/SIOG/ACS专家建议:老年直肠癌患者的个体化管理, enTitle=Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Su, guiderFrom=Eur J Surg Oncol. 2018 Aug 15., authorId=null, author=, summary=2018年8月,欧洲肿瘤外科学会(ESSO)、欧洲肛肠病学学会(ESCP)、国际老年肿瘤学会(SIOG)以及美国外科医师协会(ACS)癌症委员会共同发布了老年直肠癌患者的个体化管理建议,主要建议内容涉及多学科团队管理,患者优化,手术治疗,局部晚期疾病的治疗,肝转移同步治疗以及促进恢复路径等。 , cover=, journalId=null, articlesId=null, associationId=1697, associationName=欧洲肿瘤外科学会, associationIntro=, copyright=0, guiderPublishedTime=Wed Aug 15 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年8月,欧洲肿瘤外科学会(ESSO)、欧洲肛肠病学学会(ESCP)、国际老年肿瘤学会(SIOG)以及美国外科医师协会(ACS)癌症委员会共同发布了老年直肠癌患者的个体化管理建议,主要建议内容涉及多学科团队管理,患者优化,手术治疗,局部晚期疾病的治疗,肝转移同步治疗以及促进恢复路径等。 </div> <div><br> </div>拓展指南:<strong>与<font color="red">直肠癌</font>相关指南:</strong><br><ul><li><a title="WSES指南:结肠癌和直肠癌急症-梗阻和穿孔" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=0a3a51c0016310ce">WSES指南:结肠癌和直肠癌急症-梗阻和穿孔</a></li> <li><a title="2018 CAG临床实践指南:非遗传性结直肠癌和腺瘤家族史个体结直肠癌筛查" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=ab59a1c0016303a5">2018 CAG临床实践指南:非遗传性结直肠癌和腺瘤家族史个体结直肠癌筛查</a></li> <li><a title="2018 WEO共识声明:结肠镜检查后以及影像检查后结直肠癌" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=33ada1c00161156c">2018 WEO共识声明:结肠镜检查后以及影像检查后结直肠癌</a></li> <li><a title="NCCN临床实践指南:直肠癌(2018.V2)" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=ca6971c0016111ea">NCCN临床实践指南:直肠癌(2018.V2)</a></li> <li><a title="中国结直肠癌肝转移诊断和综合治疗指南(2018版)" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=a5caa1c00160e694">中国结直肠癌肝转移诊断和综合治疗指南(2018版)</a></li> 更多信息请点击:<a target="_blank" href="http://www.medsci.cn/guideline/list.do?q=%E7%9B%B4%E8%82%A0%E7%99%8C">有关直肠癌更多指南</a></ul>, tagList=[TagDto(tagId=748, tagName=直肠癌), TagDto(tagId=79964, tagName=个体化管理)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5174, appHits=132, showAppHits=0, pcHits=4122, showPcHits=1230, likes=107, shares=4, comments=3, approvalStatus=1, publishedTime=Fri Aug 31 23:02:34 CST 2018, publishedTimeString=2018-08-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Aug 31 23:02:34 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 11:28:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ESSO/ESCP/SIOG/ACS专家建议:老年直肠癌患者的个体化管理)])
2018 ESSO/ESCP/SIOG/ACS专家建议:老年直肠癌患者的个体化管理
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=342072, encodeId=d3ef3420e2ce, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Sep 01 08:21:51 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342067, encodeId=f12c34206e7f, content=谢谢分享。收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Sat Sep 01 07:03:39 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342056, encodeId=7fa1342056cd, content=谢谢分享,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Sat Sep 01 06:26:46 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-01 1ddf0692m34(暂无匿称)

    学习了,谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=342072, encodeId=d3ef3420e2ce, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Sep 01 08:21:51 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342067, encodeId=f12c34206e7f, content=谢谢分享。收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Sat Sep 01 07:03:39 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342056, encodeId=7fa1342056cd, content=谢谢分享,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Sat Sep 01 06:26:46 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-01 chinadoctorliu_19344479

    谢谢分享。收藏

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=342072, encodeId=d3ef3420e2ce, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Sep 01 08:21:51 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342067, encodeId=f12c34206e7f, content=谢谢分享。收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Sat Sep 01 07:03:39 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=342056, encodeId=7fa1342056cd, content=谢谢分享,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Sat Sep 01 06:26:46 CST 2018, time=2018-09-01, status=1, ipAttribution=)]
    2018-09-01 明月清辉

    谢谢分享,学习了

    0